Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.31 |
| ▸ | TSPO | P30536 | 2/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.30 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.30 |
| ▸ | PTGES | O14684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21370073 | 0.98 | KDM4E (0.33) | KDM4EATML3MBTL1NR3C1TSPO | |
| SCHEMBL21369274 | 0.98 | KDM4E (0.33) | KDM4EATML3MBTL1NR3C1TSPO | |
| SCHEMBL20968662 | 0.98 | KDM4E (0.33) | KDM4EATML3MBTL1NR3C1TSPO | |
| SCHEMBL24947317 | 0.98 | KDM4E (0.33) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL20968636 | 0.98 | KDM4E (0.33) | KDM4EATML3MBTL1NR3C1TSPO | |
| SCHEMBL24948013 | 0.98 | KDM4E (0.33) | KDM4EATML3MBTL1NR3C1TSPO | |
| SCHEMBL24948019 | 0.98 | KDM4E (0.33) | KDM4EATML3MBTL1NR3C1TSPO | |
| SCHEMBL26710275 | 0.98 | KDM4E (0.35) | KDM4EATML3MBTL1NR3C1TSPO | |
| SCHEMBL24374242 | 0.97 | KDM4E (0.33) | KDM4EATML3MBTL1NR3C1TSPO | |
| SCHEMBL24947314 | 0.97 | KDM4E (0.34) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230354706-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-11-02 | — | — | US | disclosed |
| US-20230354706-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-11-02 | — | — | US | disclosed |
| WO-2022086297-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2022-04-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230354706-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY2, CRY1, PER2 | KDM4E 2382/4885ATM 2287/4885L3MBTL1 448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.